Max Healthcare controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile5 entries
2020
COVID-19 treatment-price criticism
During the COVID-19 outbreak, the Patparganj hospital faced criticism over reported daily treatment costs. The hospital responded that charges above ₹1 lakh per day applied only to very critical patients.
2017
Shalimar Bagh newborn-death declaration
Authorities suspended the license of Max Super Speciality Hospital, Shalimar Bagh, after a premature baby was incorrectly declared dead and was subsequently found alive. The suspension was stayed later in the month and the hospital resumed operations.
2016
Dispute over free-treatment obligations
The Delhi government included Max Super Speciality Hospital, Saket, among hospitals accused of failing to provide the required proportion of free treatment to economically disadvantaged patients under conditions associated with concessional land.
2015
Competition investigation into syringe pricing
The Competition Commission of India investigated allegations that the Patparganj hospital required patients to buy disposable syringes from its pharmacy at inflated prices. The investigation concluded in 2017 that the hospital had earned margins described as ranging from 275 percent to 525 percent and characterized the conduct as abuse of a dominant position.
2013
Mohali pacemaker negligence case
After a patient died following pacemaker implantation at Max Super Speciality Hospital, Mohali, allegations were made that an inappropriate or low-cost device had been implanted. A court later summoned the hospital's chief executive and the doctor on allegations including negligence, conspiracy and cheating. In 2017, a consumer commission ordered compensation of ₹32.94 lakh to the patient's widow, and the Punjab and Haryana High Court upheld the summoning order in 2024.